Related references
Note: Only part of the references are listed.Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications
Kenan Yalta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Galectin-3 Levels and Outcomes After Myocardial Infarction A Population-Based Study
Rabea Asleh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by beta(2)-adrenoceptor overexpression
My-Nhan Nguyen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Anahita Ghorbani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention
Giuseppe Di Tano et al.
HEART (2017)
Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling
Umesh C. Sharma et al.
HEART LUNG AND CIRCULATION (2017)
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
Yonggang Lu et al.
MOLECULAR MEDICINE REPORTS (2017)
Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis
Christian Besler et al.
CIRCULATION-HEART FAILURE (2017)
Short-term Changes in Gal 3 Circulating Levels After Acute Myocardial Infarction
Giulia Bivona et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study
Anna Lisowska et al.
ATHEROSCLEROSIS (2016)
Circulating Galectin-3 Levels Are Increased in Patients with Ischemic Heart Disease, but Are Not Influenced by Acute Myocardial Infarction
Erlend G. Singsaas et al.
CARDIOLOGY (2016)
Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction
A. Rogier van der Velde et al.
CLINICA CHIMICA ACTA (2016)
Soluble galectin-3 is associated with premature myocardial infarction
Max-Paul Winter et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
Giuseppe Vergaro et al.
HYPERTENSION (2016)
Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping
Rosario J. Perea et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
Gokhan Aksan et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
Roberto Martin-Reyes et al.
PLOS ONE (2016)
Galectin-3 is expressed in the myocardium very early post-myocardial infarction
Satwat Hashmi et al.
CARDIOVASCULAR PATHOLOGY (2015)
Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons
Christoph Ohlmeier et al.
CLINICAL RESEARCH IN CARDIOLOGY (2015)
Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus
Derya Ozturk et al.
CORONARY ARTERY DISEASE (2015)
Galectin-3 and post-myocardial infarction cardiac remodeling
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Clinical significance of plasma galectin-3 in patients with coronary artery disease
Hiroaki Kusaka et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
被撤回的出版物: ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data (Retracted article. See vol. 385, pg. 402, 2015)
Jing Li et al.
LANCET (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
Evaluation of galectin-3 levels in acute coronary syndrome
E. Gucuk Ipek et al.
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE (2015)
Temporal expression of galectin-3 following myocardial infarction
Thomas D. Milner et al.
ACTA CARDIOLOGICA (2014)
The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
Wouter C. Meijers et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice
German E. Gonzalez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Galectin-3 expression in cardiac remodeling after myocardial infarction
J. Sanchez-Mas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis
Julio Madrigal-Matute et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction treated invasively
Iwona Szadkowska et al.
BIOMARKERS (2013)
The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty
Iwona Szadkowska et al.
CARDIOLOGY JOURNAL (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction
Robin A. P. Weir et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
Dirk J. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
Inder S. Anand et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
Alison C. MacKinnon et al.
GLYCOBIOLOGY (2013)
Galectin-3: Relation to infarct scar and left ventricular function after myocardial infarction
Agnes Mayr et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Spatial and Temporal Expression, and Statin Responsiveness of Galectin-1 and Galectin-3 in Murine Atherosclerosis
Yong-Jin Lee et al.
KOREAN CIRCULATION JOURNAL (2013)
Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22
E. Wilson Grandin et al.
CLINICAL CHEMISTRY (2012)
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Gullestad et al.
EUROPEAN HEART JOURNAL (2012)
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
Natalia Lopez-Andres et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Value and Level of Galectin-3 in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Tzu-Hsien Tsai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2012)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Galectin-3 in Cardiovascular Disease
David A. Morrow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Expression of galectin-3 in mouse endometrium and its effect during embryo implantation
Huan Yang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
GALECTIN-3 PLASMA LEVELS AND CORONARY ARTERY DISEASE: A NEW POSSIBLE BIOMARKER OF ACUTE CORONARY SYNDROME
C. Falcone et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or Both
Sung-Hee Shin et al.
CIRCULATION (2010)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Galectin-3, a Novel Centrosome-associated Protein, Required for Epithelial Morphogenesis
Annett Koch et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Yun-He Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Galectin-3 mediates post-ischemic tissue remodeling
Yi-Ping Yan et al.
BRAIN RESEARCH (2009)
Patient Health Status and Costs in Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Paul S. Chan et al.
CIRCULATION (2009)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice
Maurice Nachtigal et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction
Marianna Papaspyridonos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression and immunohistochemical localization of galectin-3 in various-mouse tissues
Heechul Kim et al.
CELL BIOLOGY INTERNATIONAL (2007)
Membrane trafficking of CD98 and its ligand galectin 3 in BeWo cells - implication for placental cell fusion
Paola Dalton et al.
FEBS JOURNAL (2007)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Galectin-3:: An open-ended story
J Dumic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Determinants and prognostic impact of heart failure complicating acute coronary syndromes observations from The Global Registry of Acute Coronary Events (GRACE)
PG Steg et al.
CIRCULATION (2004)
Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction
F Yang et al.
HYPERTENSION (2004)
Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins
K Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Intracellular functions of galectins
FT Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
Share Paper
